Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Renewal of SciNote Electronic Laboratory Notebook (ELN) Software Licenses

Closed
FDA-75F40126Q00115Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract is for the renewal of SciNote Electronic Laboratory Notebook (ELN) software licenses and associated support services for FDA/CDER laboratories, with an estimated 270 licenses required under a firm-fixed-price, lowest price technically acceptable (LPTA) award mechanism. The contractor must deliver software licensing for on-premises deployment, ongoing technical support for current integrations with ItemAware, ChemDoodle, and Microsoft Office Online, and comprehensive professional services including configuration, implementation, and training for up to 270 users. All solutions, including “or equal” alternatives, must fully meet or exceed the technical requirements outlined in Sections 4, 5, and 6 of the solicitation, with “or equal” proposals requiring a detailed point-by-point demonstration of equivalence to the specified SciNote functionalities. Compliance with Section 508 accessibility standards is mandatory, requiring submission of either an HHS Section 508 Accessibility Conformance Checklist or a VPAT-based Accessibility Conformance Report. The contract includes a base year starting September 29, 2026, and two option years, extending performance through September 28, 2029, with all deliverables to be installed and supported at designated FDA locations in Saint Louis, Missouri, and Silver Spring, Maryland. The contractor is required to provide complete documentation including validated protocols, user manuals, and system configuration records, and must ensure all software and related services conform to federal information security standards, including encryption using FIPS 140-validated modules, media sanitization per NIST SP 800-88, and secure key management. All personnel accessing government systems must undergo appropriate background investigations as defined by HHS security tiers, complete FDA-mandated security and privacy training annually, and sign non-disclosure agreements using FDA Form 3398. The contractor must comply with prohibitions on use of covered telecommunications and software from banned entities such as Kaspersky Lab or ByteDance, adhere to federal supply chain security requirements, and avoid any EULA or TOS provisions that conflict with federal law. Invoices must be submitted exclusively through the Treasury’s Invoice Processing Platform, and all deliverables are subject to acceptance inspection at the delivery site based on conformance to contract specifications, operational functionality, and accessibility compliance. Failure to meet any technical requirement will result in rejection, and award will be granted solely to the technically acceptable offeror with the lowest price.

General Info

License renewal and support for SciNote ELN software with FDA compliance, lowest price wins.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

Contract Value

$537,130.92

NAICS

513210 - Software PublishersView NAICS

Place of Performance

Saint Louis, MO, 63110, USA

Set-Aside

NONE

Awardee

AXIOM CONSULTANTS, INCView Profile

Award Issued Date

Documents

(1)

RFQ FDA-75F40126Q00115 Renewal of SciNote ELN Software Licenses

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts

Full Description

Show more

This request is to renew SciNote Electronic Laboratory Notebook (ELN) software (licenses and support) for the FDA/CDER labs. Brand name equivalent products shall meet all technical requirements, and the contractor must provide configuration, professional
services, training, and implementation services to transition existing ELN into equivalent ELN. SciNote ELN software is within lifecycle of approved software and satisfies all security and technology requirements from FDA. SciNote ELN software is installed on
premises and actively used by FDA labs. Contractor must provide renewal for licenses, support for current on-premises installations, support for current integration with inventory system (ItemAware), ChemDoodle software, and Microsoft Office Online. Contractor must provide training and professional services.


The Contractor shall provide FDA/CDER labs with consultation and integration assistance including documentation and training deliverables. The required documentation from the contractor will include all executed validation protocols, reports and User Guide/manual for reference.


The Government will award a contract resulting from this solicitation to the responsible quoter as a fixedprice contract on the lowest price technically acceptable (LPTA) evaluation method. Award will be made on the basis of the lowest evaluated price meeting or exceeding the noncost factor (technical conformance to the requirements of the solicitation). The Quoter's initial quotation shall contain the Quoter's best terms from a price standpoint. Failure to demonstrate meeting any of the requirements will result in a rating of technically unacceptable and will not beconsidered for award.


The following factors shall be used to evaluate quotes:


- Total price.


- Technical features meeting/exceedingrequirements specified in Section 4, 5 and 6.


In addition, "or Equal" quotes will be evaluated in accordance with FAR provision52.211-6: Brand Name or Equal, paragraph (c). Each "or Equal" solution proposed shall demonstrate:


- A technical volume withdetailed point-by-point description of how the equal to product meets all the salient characteristics of this solicitation, specialized inSections 4, 5, and 6.


- Completed Section 508 Product Accessibility Templates (PAT) in full text.


For further details, please review the attached RFQ FDA-75F40126Q00115_ document.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS